Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Beijing Succeeder Technology's ROE % for the quarter that ended in Mar. 2026 was 4.55%. Beijing Succeeder Technology's PB Ratio for the quarter that ended in Mar. 2026 was 1.83.
Beijing Succeeder Technology's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 2.49%.
Beijing Succeeder Technology ROE % Adjusted to Book Value Related Terms
Beijing Succeeder Technology ROE % Adjusted to Book Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Succeeder Technology ROE % Adjusted to Book Value Chart
SHSE:688338 vs ABT, SYK, MDT: ROE % Adjusted to Book Value Comparison
For the Medical Devices subindustry, Beijing Succeeder Technology's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Succeeder Technology ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Beijing Succeeder Technology's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Beijing Succeeder Technology's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 2.49% mean?
Beijing Succeeder Technology (SHSE:688338) has a ROE % Adjusted to Book Value of 2.49% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Beijing Succeeder Technology and its competitors.
Is Beijing Succeeder Technology's ROE % Adjusted to Book Value too high?
Beijing Succeeder Technology's current ROE % Adjusted to Book Value is 2.49%. Overall, Beijing Succeeder Technology has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Beijing Succeeder Technology's ROE % Adjusted to Book Value compare to ABT and SYK?
Beijing Succeeder Technology's ROE % Adjusted to Book Value of 2.49% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Beijing Succeeder Technology and its competitors. Beijing Succeeder Technology's current ROE % Adjusted to Book Value is 2.49%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Succeeder Technology stock overvalued right now?
Based on GuruFocus' analysis, Beijing Succeeder Technology (SHSE:688338) is currently considered Fairly Valued. The stock's GF Value™ is ¥30.49, compared to a current price of ¥29.13 — trading 4.5% below its estimated fair value. The current ROE % Adjusted to Book Value is 2.49%. Beijing Succeeder Technology's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Beijing Succeeder Technology (SHSE:688338), the current ROE % Adjusted to Book Value is 2.49% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Succeeder Technology (SHSE:688338) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Succeeder Technology stock appears to be undervalued.
The current stock price of ¥29.13 is trading 4.5% below its estimated GF Value™ of ¥30.49.
GuruFocus considers Beijing Succeeder Technology to be Fairly Valued.
Key valuation signals for SHSE:688338:
ROE % Adjusted to Book Value: 2.49%
GF Value™: ¥30.49 vs. price of ¥29.13 (4.5% below fair value)
No single metric tells the full story. See the SHSE:688338 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Succeeder Technology Inc is engaged in production and sales of detection instruments, reagents and consumables in the field of in vitro diagnosis of thrombosis and hemostasis. The company develops, manufactures and sells in-vitro diagnostic products including coagulation analyzers and reagents, blood rheology analyzers, ESR analyzers and platelet aggregation analyzers. Its product portfolio includes Fully Auto Coagulation Analyzer; Semi Auto Coagulation Analyzer; ESR Analyzer; Platelet Aggregation Analyzer; and Coagulation Reagents.
86GF Score
Get the complete analysis for SHSE:688338
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688338 has been successfully added to your 
